Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years – VISION and IVY Networks, September 2023-January 2024
Related Posts
Farooqui ON, Elicker BM, Henry TS, Hahn LD, Kallianos KG, Han MK, Barr RG, Smith BM, Comellas AP, Bon J, Hansel N, Wells JM, Paine[...]
Rahaghi FN. Measures of Vascular Volume in the Lung: An Emerging Quantitative Tool for Clinical and Physiological Studies in Pulmonary Vascular Disease. Am J Respir[...]
Bendall EE, Fitzsimmons WJ, Valvano WD, Truscon R, Self WH, Halasa N, Chappell JD, Zhu Y, Safdar B, Ginde AA, Peltan ID, Gaglani M, Columbus[...]